Burk Holdings’s Gilead Sciences GILD Stock Holding History

Burk Holdings’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.6K	Buy	361 +284	+369%	+$37.4K	0.02%	156
2026 Q1	$10.7K	Buy	+77	New	+$10.8K	﹤0.01%	259

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Burk Holdings's GILD Position: Q2 2026 in Review

Burk Holdings increased its Gilead Sciences (GILD) stake by 369% in Q2 2026, buying an estimated $37.4K and bringing the position to 361 shares worth $45.6K. The position accounts for 0.02% of the portfolio, ranked #156.

Burk Holdings first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Burk Holdings held 361 shares of Gilead Sciences worth $45.6K as of Q2 2026.
Burk Holdings bought 284 Gilead Sciences shares in Q2 2026, an estimated $37.4K.
Gilead Sciences made up 0.02% of Burk Holdings's portfolio in Q2 2026, its #156 holding.
Burk Holdings first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Burk Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.